Myllykoski, Matti
Baumann, Anne
Hensley, Kenneth
Kursula, Petri http://orcid.org/0000-0001-8529-3751
Funding for this research was provided by:
Helse Vest
Sigrid Juséliuksen Säätiö
Emil Aaltosen Säätiö
Forschungs- und Wissenschaftsstiftung Hamburg
National Institutes of Health (NS082283, NS093594)
Article History
Received: 15 December 2016
Accepted: 19 December 2016
First Online: 2 January 2017
Compliance with ethical standards
:
: KH is the inventor on US patent 7,683,055 (other patents pending) covering composition and use of LK derivatives including LKE and holds equity in a company engaged in commercial development of the technology.
: This article does not contain any studies with human participants or animals performed by any of the authors.